Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ofloxacin (ausschl. Dafo. KPG), ATC S01AE01 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Monate)

DAK-GesundheitHamburg, GermanyEUR 1 / ~EUR 11082 days leftopen

Registrieren zum Speichern Documents (1)

Opportunity Score

Confidence: 60%

Complexity: low

1082 days

Deadline

supplies

Contract

Deep Portfolio Analysis

Company fit score
Missing certificates
Eligibility blockers
Bid / No-Bid recommendation

Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Non-exclusive discount agreement (Rabattvereinbarung) under §130a Abs. 8 SGB V for the active ingredient Ofloxacin (excl. eye drops, ATC S01AE01) with DAK-Gesundheit. Open admission model allowing any pharmaceutical company to join at any time. Initial term 01.08.2026-31.07.2028 with optional 1-year extension. Estimated value symbolically set at 1 EUR. Submission by email only, in German. Not a standard procurement procedure.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Submit required documents via email to [email protected] (not via e-procurement portal or post).
Documents: offer letter, signed contract accepting the discount terms, completed Annexes 1 and 2 (Annex 2 as Excel).
Deadline for initial join: documents must be received by the 5th of the month before the desired start date (e.g., for start 01.08.2026, submit by 05.07.2026).

Buyer

Name

DAK-Gesundheit

Location

Hamburg, DEU

[email protected]

Website

www.dak.de

Identifier

DE48698890

Lots (1)

#LOT-0001Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ofloxacin (ausschl. Dafo. KPG), ATC S01AE01 f. d. Z. 01.08.2026 - 31.07.2028 (zzgl. V.-Option 1x12 Monate)

Single lot covering all pharmaceutical products containing Ofloxacin in non-ophthalmic form (ATC S01AE01). Open to all interested pharmaceutical companies; non-exclusive; contract terminates automatically if an exclusive contract is concluded for the same substance.

EUR 133600000DEU